Cargando…
Microbiota Modulation in Patients with Metabolic Syndrome
Metabolic syndrome (MS) comprises a vast range of metabolic dysfunctions, which can be associated to cardiovascular disease risk factors. MS is reaching pandemic levels worldwide and it currently affects around 25% in the adult population of developed countries. The definition states for the diagnos...
Autores principales: | Araujo, Ricardo, Borges-Canha, Marta, Pimentel-Nunes, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658393/ https://www.ncbi.nlm.nih.gov/pubmed/36364752 http://dx.doi.org/10.3390/nu14214490 |
Ejemplares similares
-
Systematic Review of the Relation Between Intestinal Microbiota and Toll-Like Receptors in the Metabolic Syndrome: What Do We Know So Far?
por: Portela-Cidade, José Pedro, et al.
Publicado: (2015) -
How Is Endoscopic Submucosal Dissection for Gastrointestinal Lesions Being Implemented? Results from an International Survey
por: Araújo-Martins, Miguel, et al.
Publicado: (2020) -
Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients
por: Matijašić, Mario, et al.
Publicado: (2016) -
Subacute Thyroiditis After Severe Acute Respiratory Syndrome Coronavirus 2 Vaxzevria Vaccination in a Patient With Thyroid Autoimmunity
por: Borges Canha, Marta, et al.
Publicado: (2022) -
Bile Acid and Gut Microbiota in Irritable Bowel Syndrome
por: Min, Yang Won, et al.
Publicado: (2022)